MEDNAX (MD) Misses Q3 EPS by 17c

MEDNAX (NYSE: MD) reported Q3 EPS of $0.37, $0.17 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $489.92 million versus the consensus estimate of $512.13 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Kamada Ltd. (KMDA) Tops Q2 EPS by 4c
• Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c